Quince Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.15

-0.03 (-2.54%)

As of May 16, 2:32 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 5 56%

Sell 4 44%

Price Target

Analyst Price Target +3,390.4% upside

Low Target $31.69

Average Target $40.14

High Target $63.06

Current Price $1.15

Current
$1.15

Target
$40.14

$31.69 $40.14 avg $63.06

Scenario Analysis

Bear Case

$31.69

2,655.7%

Low target

Base Case

$40.14

+3,390.4%

Avg target

Bull Case

$63.06

+5,383.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$45.50

-97.5% from high

52-Week Low

$0.80

+43.8% from low

Target vs 52W High

$40.14

-11.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%